EW vs RGS · P/E 47, rev $3.39B vs P/E 0.6, rev $224.5M
Edwards Lifesciences Corp (EW) versus Regis Corporation Common Stock (RGS) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Regis Corporation Common Stock (RGS) is a personal services company listed on US.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported RGS revenue for 2026-06-30 was $224.5M. Net income was $6.9M. Revenue was up 6.8% from 2025-06-30 to 2026-06-30. RGS currently screens at market cap $56.5M and trailing P/E 0.6.
EW currently screens at market cap $49.91B and trailing P/E 46.9. RGS currently screens at market cap $56.5M and trailing P/E 0.6.
Not investment advice. Open the EW and RGS stock pages for the full models.
Not investment advice.